Harmony Biosciences Holdings, Inc. (HRMY) vs Viridian Therapeutics, Inc. (VRDN)
- Harmony Biosciences Holdings, Inc. HRMY 38.20 −0.18%
- Viridian Therapeutics, Inc. VRDN 19.03 −2.71%
Harmony Biosciences Holdings, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Viridian Therapeutics, Inc. are of similar size ($2.2B and $2.2B). Viridian Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 12.2×. Viridian Therapeutics, Inc. grew revenue faster over the last twelve months: 23,220.3% against 24.3%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.9% vs −544.1%) and the higher return on invested capital (29.7% vs 0.00%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 14 and Viridian Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | HRMY | VRDN | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.42% | 100.00% | 65.16% |
| Operating margin | 24.03% | (569.68%) | 0.00% |
| Net margin | 18.88% | (544.06%) | 0.00% |
| Free cash flow margin | 36.99% | (471.04%) | 0.00% |
| Return on equity | 20.46% | (86.93%) | (56.36%) |
| Return on assets | 14.61% | (46.08%) | (48.04%) |
| Return on invested capital | 29.70% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack